Aldeyra Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $1.1M | $-40.2M | $3.3M |
| FY2014 | $1.2M | $6.3M | $8.5M |
| FY2015 | $1.2M | $24.9M | $14.6M |
| FY2016 | $1.2M | $24.9M | $14.6M |
| FY2017 | $1.2M | $39.6M | $20.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | $1.1M | $-40.2M | $3.3M |
| FY2014 | $1.2M | $6.3M | $8.5M |
| FY2015 | $1.2M | $24.9M | $14.6M |
| FY2016 | $1.2M | $24.9M | $14.6M |
| FY2017 | $1.2M | $39.6M | $20.0M |